Fig. 2From: Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohortSerial audiograms for patient X, who developed profound hearing loss during MDR-TB treatmentBack to article page